Therefore, aberrant activation of VEGF-PI3K/AKT pathways by progranulin may represent one of the molecular drivers of ECCL pathology, linking histopathologic features with dysregulated molecular signaling pathways. The gene discussed is AKT1; the disease is encephalocraniocutaneous lipomatosis.